Cargando…

Abstract 2: Effectiveness and safety of early growth hormone treatment in children born small for gestational age: Long-term data from NordiNet® International Outcome Study (IOS) and ANSWER program

Background: Growth hormone (GH) is indicated for the treatment of short stature in children born small for gestational age (SGA) who fail to show catch-up growth. In pilot studies, early initiation of GH has been associated with favorable growth responses in short SGA children. However, few studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranjan, K M, Juul1, Anders, Pietropoli2, Alberto, Kelepouris3, Nicky, Geffner4, Mitchell E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Abstracts … Esicon 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067871/ http://dx.doi.org/10.4103/2230-8210.342287

Ejemplares similares

Effectiveness and Safety of Early Growth Hormone Treatment in Children Born Small for Gestational Age: Long-Term Data From NordiNet® International Outcome Study (IOS) and ANSWER Program
por: Juul, Anders, et al.
Publicado: (2021)

Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet(®) IOS and Answer Program
por: Backeljauw, Philippe, et al.
Publicado: (2023)

Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER
por: Sävendahl, Lars, et al.
Publicado: (2021)

Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study
por: Angulo, Moris, et al.
Publicado: (2020)

Abstract 7: Use of growth hormone therapy in short patients born small for gestational age: Data from real-life French clinical practice
por: Paulose, Rinz, et al.
Publicado: (2022)

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER
por: Biller, Beverly M K, et al.
Publicado: (2023)

Abstract 92: Contemporaneous association of pheochromocytoma with Cushing's syndrome
por: Acharya, Himamshu, et al.
Publicado: (2022)

Abstract 1: Efficacy and safety of novel non-steroidal mineralocorticoid receptor antagonist finerenone in the management of diabetic kidney disease: A meta-analysis
por: Dutta, Deep, et al.
Publicado: (2022)

Abstract 17: Spontaneous hypoglycaemia due to insulin autoimmune syndrome in five cases, response to steroid therapy and rituximab
por: Batra, C M, et al.
Publicado: (2022)

Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet(®) IOS and ANSWER Program
por: Sävendahl, Lars, et al.
Publicado: (2019)

Abstract 58: Favourable outcomes with therapeutic glucocorticoid regimen compared to replacement glucocorticoid regimen in primary hypophysitis
por: Das, Liza, et al.
Publicado: (2022)

Abstract 21: The burden of mealtime insulin dosing in adults and children with type 1 diabetes
por: Revanna, Manjunatha, et al.
Publicado: (2022)

Abstract 44: Persons living with diabetes in India – Their experiences and expectations from the physician
por: Selvan, Chitra, et al.
Publicado: (2022)

Abstract 43: Prevalence of islet-autoantibodies and monogenic diabetes in children with recent onset type 1 diabetes mellitus: A multicenter study
por: Jayakrishnan, C, et al.
Publicado: (2022)

PMON60 Growth Hormone (GH) Replacement Therapy (GHRT) in Patients with Adult GH Deficiency (AGHD) Aged ≥60 Years: Data from NordiNet® IOS and the ANSWER Program
por: Biller, Beverly, et al.
Publicado: (2022)

Abstract 6: Maternal efficacy, safety, and pregnancy outcomes with degludec versus detemir in the treatment of pregnant women with type 1 diabetes: An international, multicentre, randomised trial
por: Balaji, Kamaleswari, et al.
Publicado: (2022)

Abstract 84: Clinical and aetiological spectrum of thyrotoxic patients: A multi-centre analysis
por: Aggarwal, Ajay, et al.
Publicado: (2022)

Abstract 41: Effect of zoledronic acid on bone mineral density in Indian postmenopausal osteoporotic women with and without diabetes – A prospective cohort study
por: Merugu, Chandhana, et al.
Publicado: (2022)

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program
por: Biller, Beverly M. K., et al.
Publicado: (2021)

Abstract 16: Urinary metabolic signatures for differential diagnosis of diabetic and non-diabetic kidney disease
por: Basu, Madhurima, et al.
Publicado: (2022)

Abstract 66: Spectrum of sleep abnormalities in primary hypothyroidism
por: Acharya, Himamshu, et al.
Publicado: (2022)

CORRIGENDUM for “Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program”
Publicado: (2020)

Abstract 72: Prevalence, course, and predictive factors of water and electrolyte disturbances (WEDs) following transsphenoidal pituitary surgery (TSS) in patients with pituitary adenoma
por: Bhardwaj, S, et al.
Publicado: (2022)

LBMON197 Predictors Of Response To Growth Hormone Treatment In Pediatric Growth Disorders: Analysis From The Answer Program And Nordinet® IOS
por: Ross, Judith L, et al.
Publicado: (2022)

Abstract 67: Oral: Plantar temperature and pressure distribution in subjects with diabetes mellitus and chronic charcot arthropathy – A case control study
por: Paul, Jinson, et al.
Publicado: (2022)

Abstract 141: CGM-based measurements for once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-treated patients with type 2 diabetes: A post hoc analysis
por: Chandrappa, Manu, et al.
Publicado: (2022)

Abstract 90: Graves disease and parkinsonism: Is there a link?
por: Sourabh, Sagar, et al.
Publicado: (2022)

Abstract 118: Primary hyperaldosteronism presenting as subarachnoid hemorrhage
por: Panikar, Krish, et al.
Publicado: (2022)

Abstract 76: Alteration in bone metabolism and bone mineral density with chronic anti-epileptic drug therapy in North Indian population
por: Ashraf, Hamid, et al.
Publicado: (2022)

Abstract 38: Sellar mass – An unusual presentation of metastatic thyroid carcinoma
por: Sriramaneni, Nikitha, et al.
Publicado: (2022)

Abstract 65: Effects of gender affirming hormone therapy on metabolic health and body composition in gender dysphoria
por: Kiran, Baratam Hari, et al.
Publicado: (2022)

Abstract 81: A case report of elevated TSH, elevated T3 and low T4 levels and mutation in SLCA5A gene: A diagnostic dilemma
por: Kolla, Bharathi, et al.
Publicado: (2022)

Abstract 39: Exosomal long non-coding RNA help differentiate diabetic kidney disease from non-diabetic kidney disease
por: Neogi, S, et al.
Publicado: (2022)

Abstract 61: Prevalence and clinical profile of maturity onset diabetes of the young among people with diabetes attending a tertiary care institute in North India
por: Bhat, Javaid Ahmad, et al.
Publicado: (2022)

Abstract 131: Evaluation of left ventricular systolic function using global longitudinal strain by 2D speckle tracking echocardiography in patients with acromegaly
por: Singh, Nameirakpam Dhanachand, et al.
Publicado: (2022)

Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study
por: Blankenstein, Oliver, et al.
Publicado: (2017)

SAT-282 Outcomes in Children Treated with Growth Hormone for Prader-Willi Syndrome: Data from the Answer® Program and Nordinet® International Outcome Study (IOS)
por: Angulo, Moris, et al.
Publicado: (2019)

Abstract 98: Hirsutism under evaluation
por: Harshita, B, et al.
Publicado: (2022)

Abstract 108: A case of familial acromegaly
por: Appaiah, Sonali, et al.
Publicado: (2022)

Abstract 79: Adrenal insufficiency in the elderly population
por: Joseph, Neal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ma60d9hvv1kj8jj2d7svbmtcl